New Hope in Targeted Therapy for Histiocytosis

New Hope in Targeted Therapy for Histiocytosis

A new study from Memorial Sloan Kettering Cancer Center highlights the promise of ulixertinib, a targeted therapy drug that blocks ERK, for treating certain forms of histiocytosis, including Erdheim-Chester Disease (ECD). Led by Dr. Eli Diamond, a member of the ECDGA...
Ziggy Spreads a Heartfelt Message of Gratitude

Ziggy Spreads a Heartfelt Message of Gratitude

https://www.erdheim-chester.org/wp-content/uploads/2025/09/Thank-You-ECD-video.mp4 Ziggy the Zebra, the beloved mascot of the Erdheim-Chester Disease Global Alliance (ECDGA), is here with a heartfelt message of gratitude. To our patients, families, friends, and...
Save the Date: Birmingham 2026

Save the Date: Birmingham 2026

Erdheim-Chester Disease Global Alliance Announces 2026 Patient & Family Gathering and Medical Symposium Birmingham, AL — The Erdheim-Chester Disease Global Alliance (ECDGA) and UAB School of Medicine invites patients, families, healthcare professionals, and...